2nd Jun 2021 07:00
LEI: 549300Q7EXQQH6KF7Z84
2 June 2021
RTW Venture Fund Limited
Notice of Annual General Meeting
RTW Venture Fund Limited (the "Company") announces that its Annual General Meeting ("AGM") will be held at 1st Floor Royal Chambers, St Julian's Avenue St Peter Port, Guernsey on 22 June 2021 at 14.00 BST. The Notice of AGM will shortly be dispatched to all shareholders.
A copy of the Notice of AGM has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism The Notice of AGM may also be viewed on the Company's website at https://www.rtwfunds.com/venture-fund/.
The Annual Report and Audited Financial Statements for the year ended 31 December 2020 (the "Annual Report") is also available on the Company's website https://www.rtwfunds.com/venture-fund/ at and on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
The Board anticipates that at the time of the Annual General Meeting Shareholders will be able to attend the meeting in person, subject to any COVID-19 restrictions that might be imposed by the States of Guernsey. However, the Board recommends that, due to continuing uncertainty, Shareholders appoint the Chairman as proxy and provide voting instructions in advance of the AGM. Should it be required, arrangements will be made by the Company to ensure that the minimum number of Shareholders required to form a quorum will attend the AGM so that it may proceed. You will not have received a hard copy proxy form for the 2021 Annual General Meeting ("AGM") in the post. You can instead submit your proxy vote electronically by accessing the shareholder portal at www.signalshares.com, logging in and selecting the 'Vote Online Now' link. Full details of how to vote are set out in notes 2 and 3 in the Notes to the Notice of Meeting. Please submit your proxy vote so as to reach the Company's registrar as soon as possible and in any event no later than 2pm on Friday 18 June 2021 or, if you are a CREST member, by using the service provided by Euroclear. The completion of the form of proxy will not preclude a member from attending and voting in person at the meeting if it is so allowed.
The situation is developing rapidly and shareholders should note that further changes may need to be put in place at short notice in relation to the AGM this year. Updates on the status of the AGM and any changes to the proceedings of the meeting will be published on https://www.rtwfunds.com/venture-fund/ and announced to the market. If any shareholder has questions related to the business of the AGM, please submit your queries at https://www.rtwfunds.com/venture-fund/ by 14.00 BST on 18 June 2021. We will endeavour to answer every shareholder question and responses will be posted on the Company's website after the AGM.
For Further Information
RTW Investments, LP +1 (646) 597 6980Stephanie Sirota, Chief Business Officer
Alexandra Taracanova, PhD, Director of Investor Relations
Julia Enright, Senior Business Development Associate
Elysium Fund Management Limited +44 (0) 14 8181 0100
Joanna Duquemin Nicolle, Chief Executive Officer
Sadie Morrison, Managing Director
J.P. Morgan Cazenove +44 (0)20 7742 4000
William Simmonds
Jérémie Birnbaum
James Bouverat (Sales)
Barclays +44 (0)20 7623 2323
Tom Swerling
Andrew Tusa
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Visit the RTW website at www.rtwfunds.com for more information.
Related Shares:
Rtw Biotech